Granite Investment Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,944
Closed -$1.2M 250
2025
Q3
$1.2M Buy
+21,944
New +$1.1M 0.07% 189
2017
Q2
Sell
-33,114
Closed -$782K 304
2017
Q1
$782K Sell
33,114
-7,940
-19% -$157K 0.05% 249
2016
Q4
$548K Sell
41,054
-2,657
-6% -$42.9K 0.04% 274
2016
Q3
$812K Sell
43,711
-10,881
-20% -$192K 0.06% 258
2016
Q2
$669K Sell
54,592
-50,251
-48% -$378K 0.05% 258
2016
Q1
$707K Sell
104,843
-7,031
-6% -$45K 0.06% 257
2015
Q4
$1.03M Buy
111,874
+66,669
+147% +$620K 0.09% 217
2015
Q3
$813K Buy
+45,205
New +$1.04M 0.08% 236

Other funds holding EXAS

Granite Investment Partners's EXAS Position: Q4 2025 in Review

Granite Investment Partners sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 21,944 shares — an estimated $1.2M sold.

Granite Investment Partners first reported a position in EXAS in Q3 2015 and held it in 8 quarters. The position peaked at $1.2M in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Granite Investment Partners reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Granite Investment Partners sold 21,944 Exact Sciences shares in Q4 2025, an estimated $1.2M.
  • Granite Investment Partners first reported a position in Exact Sciences in Q3 2015 and held it in 8 quarters.
  • Granite Investment Partners's Exact Sciences position peaked at $1.2M in Q3 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Granite Investment Partners's 13F filing for Q4 2025, filed 12 Feb 2026.